Insider Trading February 27, 2026

AppTech Payments CEO Buys 20,000 Shares as Company Navigates Near-Term Debt Schedule

Thomas Joseph DeRosa increases his direct stake while the company discloses amended terms on a convertible promissory note

By Nina Shah APCX
AppTech Payments CEO Buys 20,000 Shares as Company Navigates Near-Term Debt Schedule
APCX

AppTech Payments Corp Chief Executive Officer Thomas Joseph DeRosa acquired 20,000 shares of the company’s common stock on February 26, 2026, paying a weighted average price of $0.3377 for a total of $6,754. The purchase increases his direct holdings to 46,096 shares as the stock has experienced notable weakness and volatility. Separately, the firm amended a $360,000 Senior Unsecured Convertible Promissory Note, revising the payment schedule and extending the maturity to January 16, 2026, with specified principal and interest amounts due on set dates.

Key Points

  • CEO Thomas Joseph DeRosa bought 20,000 AppTech Payments shares on February 26, 2026, at a weighted average price of $0.3377, totaling $6,754.
  • DeRosa now directly holds 46,096 shares; the company has a market capitalization of $13 million and a "WEAK" financial health rating.
  • AppTech amended a $360,000 Senior Unsecured Convertible Promissory Note with Eleven 11 Management LLC, extending the maturity to January 16, 2026, and specifying staged principal payments and $20,000 of interest due at maturity.

AppTech Payments Corp reported an insider purchase on February 26, 2026, when Chief Executive Officer Thomas Joseph DeRosa bought 20,000 shares of the company’s common stock. The shares were acquired at a weighted average price of $0.3377, with individual trade prices ranging from $0.33625 to $0.3382, resulting in a total cash outlay of $6,754.

Following the transaction, DeRosa’s direct ownership in AppTech Payments stands at 46,096 shares. The company carries a market capitalization of $13 million and is identified as having a "WEAK" financial health rating. Over the seven days preceding the purchase, the stock fell by nearly 13% and traded with high volatility.


In a separate filing, AppTech Payments disclosed an amendment to a Senior Unsecured Convertible Promissory Note originally issued to Eleven 11 Management LLC on June 18, 2025. The principal amount of the original note was $360,000. The amendment was executed on December 4, 2025, and the revised agreement extends the note’s maturity date to January 16, 2026.

The amended repayment schedule specifies that $50,000 of principal was due on December 5, 2025, $200,000 was scheduled for payment on December 20, 2025, and the remaining $110,000 is due on the maturity date of January 16, 2026. In addition to principal, outstanding interest totaling $20,000 is set to be paid on the maturity date.

These disclosures underscore recent insider activity alongside adjustments to the company’s short-term financing timetable. The CEO’s purchase occurred amid a period of stock weakness and volatility, while the amended promissory note lays out a compressed schedule of principal and interest payments over the immediate horizon.


Contextual note - The available disclosures document the insider purchase, the company’s market-capitalization and financial health designation, and the amended promissory note terms and schedule. No additional commentary or inference beyond these reported facts is included here.

Risks

  • Share price volatility and recent near-term decline - impacts small-cap equity investors and market participants tracking payments companies.
  • Concentrated short-term debt obligations under the amended promissory note - affects the company’s near-term liquidity and creditors.
  • Weak financial health rating - raises uncertainty for shareholders and counterparties about the company’s financial resilience.

More from Insider Trading

Marvell Technology President Sells $1.1M in Stock as Shares Trade Near Yearly High Apr 6, 2026 Edward Lampert Sells $58.5 Million in Lands’ End Stock; Company Posts Q4 Shortfall, Announces $100M Buyback Program Apr 6, 2026 NeonC/NeOnc President Buys $153,398 in Stock as Company Advances Financing and Clinical Timeline Apr 6, 2026 Edwards Lifesciences Executive Executes Option Exercise, Sells 1,019 Shares Apr 6, 2026 Penumbra Director Executes $32,822 Stock Sale Amid Deal and Upbeat Quarterly Results Apr 6, 2026